The generic drug maker Ranbaxy pleaded guilty on Monday to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold subpar drugs and made false statements to the FDA about its manufacturing practices at two factories in India, the company and federal prosecutors announced Monday. The settlement is the largest in history involving a generic manufacturer and drug safety, the Justice Department said. Ranbaxy has been functioning under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company, which is a subsidiary of the Japanese pharmaceutical company Daiichi Sankyo, submitted false data to the F.D.A. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the […]

More

Defective Baby Products Lawyer DE Of course, filing a lawsuit against the parties responsible for a Defective Baby Product will not undo the damage that has been done. However, making these parties pay for their negligence may help ease your family’s pain and suffering and ultimately may result in getting these Defective Baby Products off the market and prevent them from hurting any more innocent victims. Millions of Defective Baby Products are pulled from the market each year due to recalls by the Consumer Product Safety Commission. If your family has been affected by a Defective Baby Product and you think the negligent parties should be held responsible, Call Shelsby & Leoni today at 302- 995-6210. Delaware & Maryland Dangerous Baby Products Lawsuits No matter how big the company is that is responsible for the Defective Baby Product that put your child at risk, […]

More